14.38
+0.55(+3.98%)
Currency In USD
Address
300 Kimball Drive
Parsippany, NJ 07054
United States of America
Phone
201 847 6880
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2000
First IPO Date
March 22, 2022
| Name | Title | Pay | Year Born |
| Mr. Devdatt Kurdikar Ph.D. | President, Chief Executive Officer & Director | 2.34M | 1969 |
| Ms. Jean M. Casner | Senior Vice President & Chief Human Resources Officer | 811,218 | 1958 |
| Mr. Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary | 993,198 | 1972 |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 1.03M | 1970 |
| Mr. Jacob P. Elguicze | Senior Vice President & Chief Financial Officer | 1.12M | 1973 |
| Ms. Colleen Riley | Senior Vice President & Chief Technology Officer | 0 | 1965 |
| Mr. Tom Blount | Senior Vice President & President of North America | 0 | 1974 |
| Mr. Anthony M. Roth | Vice President, Chief Accounting Officer & Corporate Controller | 0 | 1973 |
| Mr. Pravesh Khandelwal | Vice President & Head of Investor Relations | 0 | N/A |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management | 0 | N/A |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.